Statnews
Published October 6, 2026 · Updated October 7, 2026
Pharmalittle: U.S. funding psychedelic trials, AZ opens R&D center - STAT News
Read the full story at Statnews
AstraZeneca's pivot towards the U.S. market has continued with the opening of a new R&D center in the biotech hotspot of Cambridge, Mass.
Surfaced by this Google Alert
- Psychedelic biotech